Cargando…
Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib
BACKGROUND: Hepatocellular carcinoma (HCC) treatment remains a big challenge in the field of oncology. The liver disease (viral or not viral) underlying HCC turned out to be crucial in determining the biologic behavior of the tumor, including its response to treatment. The aim of this analysis was t...
Ejemplares similares
-
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
por: Rimini, M., et al.
Publicado: (2022) -
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma
por: Rapposelli, I.G., et al.
Publicado: (2021) -
Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma
por: Miyahara, K, et al.
Publicado: (2013) -
Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma
por: Toshikuni, N, et al.
Publicado: (2000) -
Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma
por: Kariyama, K, et al.
Publicado: (1999)